Gross Margin

Beyond its first-ever dividend, Covalon's true story is one of clinical innovation driving record sales, navigating market shifts, and funding global growth.

As EVgo nears breakeven, it brings in a seasoned financial architect from the energy sector to steer its capital-intensive buildout toward profitability.

The return of a pharma-finance veteran to MediPharm's board isn't just a personnel change; it's a strategic move to secure its global pharmaceutical ambitions.

Borr Drilling leverages complex debt and equity financing to acquire five premium rigs, a high-stakes bet on a strengthening offshore drilling market.

Chatham Lodging Trust's dividend hike isn't just a payout. It’s a strategic signal about the future of upscale travel and savvy hotel investment.

A struggling interactive entertainment firm bets its future on gold, targeting Malaysia's booming market. A look at the high-stakes pivot shaking up BHAT.

Unisync Corp. engineered a dramatic return to profitability. We explore the deep operational changes and strategic wins that fueled this impressive turnaround.

Commercial Metals Company's fourth responsibility award isn't just PR. We decode how its deep ESG integration is a strategic moat in a changing market.

Husqvarna unveils a massive cost-cutting plan alongside ambitious growth and green targets. Can this strategic pivot secure its future market leadership?

The fight for STAAR Surgical heats up. Alcon's new $1.6B offer isn't enough for its largest shareholder, who alleges a deeply conflicted sales process.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

After a major turnaround, playable media firm Super League is betting its future on digital assets, bringing in heavyweights to lead its charge into Web3.

New data reveals a massive, quiet market for spiritual wellness among younger generations. Investors are taking note of platforms monetizing this trend.

Tempus AI's research at a key symposium shows its AI-driven edge, turning vast patient data into a powerful asset that could reshape oncology and investor outlooks.

After a financial tightrope walk, Actelis Networks is back in Nasdaq's good graces. But the real story is its mission to secure our future's IoT.

The fashion giant beat earnings and initiated a dividend, but declining sales and consumer uncertainty reveal a complex picture for the apparel industry.

The platform's 2025 report reveals more than just charity; it's a real-time indicator of economic distress, disaster response, and tech-driven mutual aid.

A new Solana meme coin is turning failure into a feature, offering tokens to traders for their verified losses. Is it a gimmick or the future of engagement?

A breakthrough eco-friendly antioxidant, SA6000, could slash the environmental impact of tires. But can this molecular innovation scale for global impact?